BrightHeart’s AI demonstrates promise in congenital heart defect detection

The software was found to improve CHD detection by more than 15% and provide conclusions in 98.8% of exams.

Previous
Previous

BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations

Next
Next

BrightHeart’s AI software boosts prenatal heart defect detection by over 15%: study